What is the recommended treatment for simple cystitis caused by Citrobacter koseri, specifically using nitrofurantoin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Citrobacter koseri Simple Cystitis with Nitrofurantoin

Nitrofurantoin is NOT recommended for empiric treatment of simple cystitis caused by Citrobacter koseri because this organism is intrinsically resistant to nitrofurantoin.

Critical Pathogen-Specific Consideration

  • Citrobacter species, including C. koseri, are intrinsically resistant to nitrofurantoin and should never be treated with this agent, regardless of what susceptibility testing may suggest 1, 2.

  • This is similar to other intrinsically resistant uropathogens like Proteus species, where nitrofurantoin treatment failures are expected even when renal function is normal 3.

Appropriate Treatment Options for Citrobacter koseri Cystitis

Since nitrofurantoin is not appropriate, you should select from these alternatives based on susceptibility testing:

First-Line Alternatives:

  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (if local resistance rates are <20% and organism is susceptible) 4, 5.

  • Amoxicillin-clavulanate (dosing per local protocols for 3-5 days) is recommended as a first-choice option for lower UTIs 4.

Second-Line Options:

  • Oral cephalosporins (cefadroxil 500 mg twice daily for 3 days, or cephalexin) if local E. coli resistance is <20% - this typically extends to Citrobacter species 5, 1.

  • Fluoroquinolones (ciprofloxacin) should be reserved for cases where other options are not suitable due to resistance or allergy, given concerns about collateral damage and the FDA's serious safety warnings 4, 5.

Common Pitfall to Avoid

  • The most critical error would be using nitrofurantoin empirically without knowing the causative organism. While nitrofurantoin is an excellent first-line agent for typical uncomplicated cystitis (predominantly caused by E. coli), it has a predictable spectrum gap that includes Citrobacter, Proteus, Serratia, and Pseudomonas species 1, 2, 3.

Clinical Algorithm

  1. If organism is unknown (empiric therapy): Use nitrofurantoin 100 mg twice daily for 5 days, amoxicillin-clavulanate, or trimethoprim-sulfamethoxazole as first-line options 4, 5.

  2. If Citrobacter koseri is identified: Immediately switch from nitrofurantoin to an appropriate alternative based on susceptibility testing (trimethoprim-sulfamethoxazole, amoxicillin-clavulanate, or oral cephalosporin) 4, 5, 1.

  3. If treatment fails: Obtain urine culture and susceptibility testing, then retreat with a 7-day regimen using a different agent 5.

References

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Uncomplicated Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.